Telehealth is great — until it isn't enough
Telehealth GLP-1 programs work well for the majority of patients during routine treatment: intake, titration, stable maintenance, and standard refills. But there are clinical situations where a screen and a chat box aren't sufficient. Recognizing when to escalate to in-person care can prevent complications and improve outcomes.
Situation 1: Persistent or severe side effects
Nausea, constipation, and mild GI discomfort during titration are normal and manageable via telehealth. But if you're experiencing severe abdominal pain that doesn't resolve (possible pancreatitis or gallbladder issues), inability to keep food or liquids down for more than 24 hours, signs of dehydration despite efforts to hydrate, or unexplained changes in heart rate or blood pressure — these need hands-on clinical evaluation. An in-person provider can perform a physical exam, order imaging, and rule out complications that can't be assessed through a screen.
Situation 2: Complex comorbidity management
If you're managing type 2 diabetes, cardiovascular disease, or kidney disease alongside GLP-1 treatment, the interactions between your GLP-1 medication and your other treatments may need closer monitoring than telehealth can provide. Blood pressure readings, physical cardiovascular assessment, and detailed lab interpretation are better done in person when multiple conditions are being managed simultaneously.
Situation 3: Weight loss plateau beyond 3 months
Plateaus are normal in GLP-1 treatment — weight loss decelerates naturally as you lose weight. But a sustained plateau (no weight change for 3+ months at an adequate dose) may indicate that your current medication or dose needs re-evaluation, hormonal or metabolic factors are limiting further progress, or body composition changes (muscle loss) are masking fat loss on the scale. An in-person provider can perform body composition analysis (DEXA scan, bioimpedance), order detailed metabolic panels, and conduct a comprehensive physical assessment that goes beyond what telehealth can offer.
Situation 4: Transition to maintenance or discontinuation
If you're planning to reduce your dose, transition to a maintenance protocol, or discontinue GLP-1 treatment, in-person guidance is valuable. Your provider can assess your current body composition, discuss evidence-based strategies for weight maintenance, monitor for rebound effects, and adjust any related medications (blood pressure, diabetes) as your weight stabilizes.
How to make the transition
Transitioning from telehealth to in-person doesn't mean abandoning your telehealth provider. Many patients use a hybrid model: routine refills and check-ins via telehealth, with periodic in-person visits for comprehensive assessment. If your telehealth provider can share your records with a local physician, the transition is seamless.